Genscript Biotech Reports 2022 Annual Results*

Non-Cell Therapy Achieved 31.4% Adjusted Net Profit Growth Cell Therapy Business Revenue Surged By 70% Revenue of the Group for the year ended December 31,...

Related Keywords

China ,Nanjing ,Jiangsu ,Japan ,Sherry Shao ,Japan Ministry Of Health ,Genscript Nanjing Co Ltd ,Revenue Of The Group ,Genscript Group ,Non Cell Therapy Achieved ,Adjusted Net Profit ,Script Biotech ,Legend Biotech ,Reporting Period ,European Commission ,Results Announcement ,Genscript Nanjing Co ,Ltd ,